Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sylvia Nieuwenhuis

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Neuromuscular Diseases|May 22, 2025
Altered reversal and extinction learning in the DMSXL mouse model of type I myotonic dystrophy (DM1): An exploratory studySylvia Nieuwenhuis, Denys Kozakov, Kasia Kapusta, et al.
Frontiers in Neurology|December 19, 2019
Insulin Signaling as a Key Moderator in Myotonic Dystrophy Type 1Sylvia Nieuwenhuis, Kees Okkersen, Joanna Widomska, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|February 26, 2015
Interferon-Beta, a Decisive Factor in Angiogenesis and ArteriogenesisCansu Yıldırım, Sylvia Nieuwenhuis, Paul F Teunissen, et al.
International Journal of Molecular Sciences|March 25, 2022
Blood Transcriptome Profiling Links Immunity to Disease Severity in Myotonic Dystrophy Type 1 (DM1)Sylvia Nieuwenhuis, Joanna Widomska, Paul Blom, et al.
Plos One|February 6, 2014
Changes in Cx43 and NaV1.5 expression precede the occurrence of substantial fibrosis in calcineurin-induced murine cardiac hypertrophyMagda S C Fontes, Antonia J A Raaijmakers, Tessa van Doorn, et al.
Plos One|April 18, 2015
Galectin-2 induces a proinflammatory, anti-arteriogenic phenotype in monocytes and macrophagesCansu Yıldırım, Daphne Y S Vogel, Maurits R Hollander, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Neuromuscular Diseases|May 22, 2025
Altered reversal and extinction learning in the DMSXL mouse model of type I myotonic dystrophy (DM1): An exploratory studySylvia Nieuwenhuis, Denys Kozakov, Kasia Kapusta, et al.
Frontiers in Neurology|December 19, 2019
Insulin Signaling as a Key Moderator in Myotonic Dystrophy Type 1Sylvia Nieuwenhuis, Kees Okkersen, Joanna Widomska, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|February 26, 2015
Interferon-Beta, a Decisive Factor in Angiogenesis and ArteriogenesisCansu Yıldırım, Sylvia Nieuwenhuis, Paul F Teunissen, et al.
International Journal of Molecular Sciences|March 25, 2022
Blood Transcriptome Profiling Links Immunity to Disease Severity in Myotonic Dystrophy Type 1 (DM1)Sylvia Nieuwenhuis, Joanna Widomska, Paul Blom, et al.
Plos One|February 6, 2014
Changes in Cx43 and NaV1.5 expression precede the occurrence of substantial fibrosis in calcineurin-induced murine cardiac hypertrophyMagda S C Fontes, Antonia J A Raaijmakers, Tessa van Doorn, et al.
Plos One|April 18, 2015
Galectin-2 induces a proinflammatory, anti-arteriogenic phenotype in monocytes and macrophagesCansu Yıldırım, Daphne Y S Vogel, Maurits R Hollander, et al.
Pageof 1